PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Medicines Patent Pool, Geneva, Switzerland.\', \'Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.\', \'Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.\', \'Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.\', \'Department of Women and Child Health, University of Padova, Padova, Italy.\', \'World Health Organization, Geneva, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/INF.0000000000003331
?:doi
?:hasPublicationType
?:journal
  • The Pediatric infectious disease journal
is ?:pmid of
?:pmid
?:pmid
  • 34784302
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34784302>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34784302>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all